Semaglutide: Clinical Trials

3 trials for Semaglutide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting, 1 unknown. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Completed 1, Recruiting 1, Unknown 1

Follow Semaglutide: new trials by email Literature Review of Semaglutide trials Research Report on Semaglutide

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Semaglutide Improves Metabolic Abnormalities and Fertility in Obese Infertile Women With Polycystic Ovary Syndrome
Metformin Hydrochloride 500 MG, Semaglutide, 1.34 mg/mL, Semaglutide, 1.34 mg/mL and Metformin Hydrochloride 500 MG - PCOS (Polycystic Ovary Syndrome), Semaglutide
Phase 4UnknownPeking University First Hospital752023-05-092024-03-25
The Impact of Semaglutide Compared to Energy Restriction on Type 2 Diabetes
semaglutide, caloric restriction - Type 2 Diabetes Mellitus (T2DM), Semaglutide
Phase 4RecruitingSecond Affiliated Hospital of Nanchang University1002023-02-102026-04-02
The Effects of Semaglutide on Taste, Tongue Tissue Transcriptome, Gastric Emptying and Central Neural Response in Women With PCOS and Obesity
Semaglutide, Placebo - PCOS, Semaglutide
Phase 4CompletedUniversity Medical Centre Ljubljana302019-11-022023-09-08

Narrower conditions

Diabetes Mellitus, Type 2 (1)  ·  Dysgeusia (1)  ·  Obesity (1)  ·  Polycystic Ovary Syndrome (1)

Broader conditions

Endocrine System Diseases (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Adnexal Diseases (1)  ·  Body Weight (1)  ·  Cysts (1)  ·  Diabetes Mellitus (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Genital Diseases (1)  ·  Genital Diseases, Female (1)  ·  Glucose Metabolism Disorders (1)  ·  Gonadal Disorders (1)  ·  Metabolic Diseases (1)

Interventions

semaglutide (3)  ·  Caloric Restriction (2)  ·  Exercise (1)  ·  Metformin (1)

Sponsors

Peking University First Hospital (1)  ·  Second Affiliated Hospital of Nanchang University (1)  ·  University Medical Centre Ljubljana (1)

Countries

China (2)  ·  Slovenia (1)

Top investigators

Tingting Zhang, M.D. (1)

Results publications

PMID 24362411, PMID 25885106, PMID 28834553, PMID 29703793, PMID 31229399, PMID 32442310, PMID 34281590, PMID 34455568, PMID 34732660, PMID 35829765, PMID 35951627, PMID 36060969